Als inhibitors - Open Access .click

Results 281 to 290 of about 112,765 (306)

Some of the next articles are maybe not open access.

Ovarialkarzinom: PARP-Inhibitor wirksamer als Chemotherapie?

gynäkologie + geburtshilfe, 2022
openaire +1 more source

A diversity of mechanisms endows resistance to ALS inhibitors in poppy

2011
Resistance to herbicides can be due to alteration(s) of the herbicide target site (target-site resistance, TSR) or to other mechanisms (non-target-site resistance, NTSR). We investigated the diversity of mechanisms conferring resistance to herbicides inhibiting acetolactate synthase (ALS) in corn poppy (Papaver rhoeas).
Délye +4 more
openaire +1 more source

Neuartiger Inhibitor als letzte Option?

InFo Hämatologie + Onkologie, 2019
openaire +1 more source

Bruton-Tyrosinkinase-Inhibitor als Frontlinientherapie bei CLL

Im Fokus Onkologie, 2021
openaire +1 more source

Target Site-Based Resistance to ALS Inhibitors, Glyphosate, and PPO Inhibitors in an <i>Amaranthus palmeri</i> Accession from Mississippi

American Journal of Plant Sciences, 2020
Vijay K Nandula, Darci A Giacomini, William T Molin +2 more
exaly

Evolocumab als erster PCSK9-Inhibitor zugelassen

CardioVasc, 2015
openaire +1 more source

Molecular basis and genetic characterisation of evolved resistance to ALS-inhibitors in Papaver rhoeas

Plant Science, 2004
Laura Scarabel, Nicola Carraro, Maurizio Sattin +2 more
exaly

Occurrence of Resistance to ALS Inhibitors in European Cyperus esculentus L.: Characterisation and Implications for Management

Agronomy, 2020
Laura Scarabel, Maurizio Sattin
exaly